Likewise, the high expression of OR51E1 in somatostatin receptor-negative lung carcinoids and in small intestine neuroendocrine carcinomas makes OR51E1 a potential novel diagnostic biomarker in these types of tumor [27,28]. This evidence concerns the gene OR51E1 and neoplasm.